Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis

Alessandra Corazza, Fabio Pettirossi, Paolo Viglino, Giuliana Verdone, Julian Garcia, Pascal Dumy, Sofia Giorgetti, Palma Mangione, Sara Raimondi, Monica Stoppini, Vittorio Bellotti, Gennaro Esposito

    Research output: Contribution to journalArticle

    Abstract

    Three variants of human β2-Microglobulin (β 2-m) were compared with wild-type protein. For two variants, namely the mutant RSAβ2-m and the form devoid of the N-terminal tripeptide (ΔN3β2-m), a reduced unfolding free energy was measured compared with wild-type βm, whereas an increased stability was observed for the mutant H31Yβ2-m. The solution structure could be determined by 1H NMR spectroscopy and restrained modeling only for RSAβ2m that showed the same conformation as the parent species, except for deviations at the interstrand loops. Analogous conclusions were reached for H31Yβ2-m and ΔN3β 2-m. Precipitation and unfolding were observed over time periods shorter than 4-6 weeks with all the variants and, sometimes, with wild-type protein. The rate of structured protein loss from solution as a result of precipitation and unfolding always showed pseudo-zeroth order kinetics. This and the failure to observe an unfolded species without precipitation suggest that a nucleated conformational conversion scheme should apply for β 2-m fibrillogenesis. The mechanism is consistent with the previous and present results on β2-m amyloid transition, provided a nucleated oligomeric species be considered the stable intermediate of fibrillogenesis, the monomeric intermediate being the necessary transition step along the pathway from the native protein to the nucleated oligomer.

    Original languageEnglish (US)
    Pages (from-to)9176-9189
    Number of pages14
    JournalJournal of Biological Chemistry
    Volume279
    Issue number10
    DOIs
    StatePublished - Mar 5 2004

    Fingerprint

    Proteins
    Oligomers
    Amyloid
    Nuclear magnetic resonance spectroscopy
    Free energy
    Conformations
    Magnetic Resonance Spectroscopy
    Kinetics
    Proton Magnetic Resonance Spectroscopy

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology
    • Cell Biology

    Cite this

    Corazza, A., Pettirossi, F., Viglino, P., Verdone, G., Garcia, J., Dumy, P., ... Esposito, G. (2004). Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis. Journal of Biological Chemistry, 279(10), 9176-9189. https://doi.org/10.1074/jbc.M310779200

    Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis. / Corazza, Alessandra; Pettirossi, Fabio; Viglino, Paolo; Verdone, Giuliana; Garcia, Julian; Dumy, Pascal; Giorgetti, Sofia; Mangione, Palma; Raimondi, Sara; Stoppini, Monica; Bellotti, Vittorio; Esposito, Gennaro.

    In: Journal of Biological Chemistry, Vol. 279, No. 10, 05.03.2004, p. 9176-9189.

    Research output: Contribution to journalArticle

    Corazza, A, Pettirossi, F, Viglino, P, Verdone, G, Garcia, J, Dumy, P, Giorgetti, S, Mangione, P, Raimondi, S, Stoppini, M, Bellotti, V & Esposito, G 2004, 'Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis', Journal of Biological Chemistry, vol. 279, no. 10, pp. 9176-9189. https://doi.org/10.1074/jbc.M310779200
    Corazza A, Pettirossi F, Viglino P, Verdone G, Garcia J, Dumy P et al. Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis. Journal of Biological Chemistry. 2004 Mar 5;279(10):9176-9189. https://doi.org/10.1074/jbc.M310779200
    Corazza, Alessandra ; Pettirossi, Fabio ; Viglino, Paolo ; Verdone, Giuliana ; Garcia, Julian ; Dumy, Pascal ; Giorgetti, Sofia ; Mangione, Palma ; Raimondi, Sara ; Stoppini, Monica ; Bellotti, Vittorio ; Esposito, Gennaro. / Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 10. pp. 9176-9189.
    @article{4c67c182d942486997cb174d6aa940bb,
    title = "Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis",
    abstract = "Three variants of human β2-Microglobulin (β 2-m) were compared with wild-type protein. For two variants, namely the mutant RSAβ2-m and the form devoid of the N-terminal tripeptide (ΔN3β2-m), a reduced unfolding free energy was measured compared with wild-type βm, whereas an increased stability was observed for the mutant H31Yβ2-m. The solution structure could be determined by 1H NMR spectroscopy and restrained modeling only for RSAβ2m that showed the same conformation as the parent species, except for deviations at the interstrand loops. Analogous conclusions were reached for H31Yβ2-m and ΔN3β 2-m. Precipitation and unfolding were observed over time periods shorter than 4-6 weeks with all the variants and, sometimes, with wild-type protein. The rate of structured protein loss from solution as a result of precipitation and unfolding always showed pseudo-zeroth order kinetics. This and the failure to observe an unfolded species without precipitation suggest that a nucleated conformational conversion scheme should apply for β 2-m fibrillogenesis. The mechanism is consistent with the previous and present results on β2-m amyloid transition, provided a nucleated oligomeric species be considered the stable intermediate of fibrillogenesis, the monomeric intermediate being the necessary transition step along the pathway from the native protein to the nucleated oligomer.",
    author = "Alessandra Corazza and Fabio Pettirossi and Paolo Viglino and Giuliana Verdone and Julian Garcia and Pascal Dumy and Sofia Giorgetti and Palma Mangione and Sara Raimondi and Monica Stoppini and Vittorio Bellotti and Gennaro Esposito",
    year = "2004",
    month = "3",
    day = "5",
    doi = "10.1074/jbc.M310779200",
    language = "English (US)",
    volume = "279",
    pages = "9176--9189",
    journal = "Journal of Biological Chemistry",
    issn = "0021-9258",
    publisher = "American Society for Biochemistry and Molecular Biology Inc.",
    number = "10",

    }

    TY - JOUR

    T1 - Properties of Some Variants of Human β2- Microglobulin and Amyloidogenesis

    AU - Corazza, Alessandra

    AU - Pettirossi, Fabio

    AU - Viglino, Paolo

    AU - Verdone, Giuliana

    AU - Garcia, Julian

    AU - Dumy, Pascal

    AU - Giorgetti, Sofia

    AU - Mangione, Palma

    AU - Raimondi, Sara

    AU - Stoppini, Monica

    AU - Bellotti, Vittorio

    AU - Esposito, Gennaro

    PY - 2004/3/5

    Y1 - 2004/3/5

    N2 - Three variants of human β2-Microglobulin (β 2-m) were compared with wild-type protein. For two variants, namely the mutant RSAβ2-m and the form devoid of the N-terminal tripeptide (ΔN3β2-m), a reduced unfolding free energy was measured compared with wild-type βm, whereas an increased stability was observed for the mutant H31Yβ2-m. The solution structure could be determined by 1H NMR spectroscopy and restrained modeling only for RSAβ2m that showed the same conformation as the parent species, except for deviations at the interstrand loops. Analogous conclusions were reached for H31Yβ2-m and ΔN3β 2-m. Precipitation and unfolding were observed over time periods shorter than 4-6 weeks with all the variants and, sometimes, with wild-type protein. The rate of structured protein loss from solution as a result of precipitation and unfolding always showed pseudo-zeroth order kinetics. This and the failure to observe an unfolded species without precipitation suggest that a nucleated conformational conversion scheme should apply for β 2-m fibrillogenesis. The mechanism is consistent with the previous and present results on β2-m amyloid transition, provided a nucleated oligomeric species be considered the stable intermediate of fibrillogenesis, the monomeric intermediate being the necessary transition step along the pathway from the native protein to the nucleated oligomer.

    AB - Three variants of human β2-Microglobulin (β 2-m) were compared with wild-type protein. For two variants, namely the mutant RSAβ2-m and the form devoid of the N-terminal tripeptide (ΔN3β2-m), a reduced unfolding free energy was measured compared with wild-type βm, whereas an increased stability was observed for the mutant H31Yβ2-m. The solution structure could be determined by 1H NMR spectroscopy and restrained modeling only for RSAβ2m that showed the same conformation as the parent species, except for deviations at the interstrand loops. Analogous conclusions were reached for H31Yβ2-m and ΔN3β 2-m. Precipitation and unfolding were observed over time periods shorter than 4-6 weeks with all the variants and, sometimes, with wild-type protein. The rate of structured protein loss from solution as a result of precipitation and unfolding always showed pseudo-zeroth order kinetics. This and the failure to observe an unfolded species without precipitation suggest that a nucleated conformational conversion scheme should apply for β 2-m fibrillogenesis. The mechanism is consistent with the previous and present results on β2-m amyloid transition, provided a nucleated oligomeric species be considered the stable intermediate of fibrillogenesis, the monomeric intermediate being the necessary transition step along the pathway from the native protein to the nucleated oligomer.

    UR - http://www.scopus.com/inward/record.url?scp=10744219788&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=10744219788&partnerID=8YFLogxK

    U2 - 10.1074/jbc.M310779200

    DO - 10.1074/jbc.M310779200

    M3 - Article

    VL - 279

    SP - 9176

    EP - 9189

    JO - Journal of Biological Chemistry

    JF - Journal of Biological Chemistry

    SN - 0021-9258

    IS - 10

    ER -